|
Geron Bio
h7 hesc line ![]() H7 Hesc Line, supplied by Geron Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/h7 hesc line/product/Geron Bio Average 90 stars, based on 1 article reviews
h7 hesc line - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
StemCells Inc
hesc lines ![]() Hesc Lines, supplied by StemCells Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hesc lines/product/StemCells Inc Average 90 stars, based on 1 article reviews
hesc lines - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
BresaGen Inc
bgo1 hes cells ![]() Bgo1 Hes Cells, supplied by BresaGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bgo1 hes cells/product/BresaGen Inc Average 90 stars, based on 1 article reviews
bgo1 hes cells - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Aruna Biomedical
human embryonic stem cell-derived mesenchymal stem cells (hmsc) ![]() Human Embryonic Stem Cell Derived Mesenchymal Stem Cells (Hmsc), supplied by Aruna Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human embryonic stem cell-derived mesenchymal stem cells (hmsc)/product/Aruna Biomedical Average 90 stars, based on 1 article reviews
human embryonic stem cell-derived mesenchymal stem cells (hmsc) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
hesc line shhes8 ![]() Hesc Line Shhes8, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hesc line shhes8/product/STEMCELL Technologies Inc Average 90 stars, based on 1 article reviews
hesc line shhes8 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
BresaGen Inc
hesbgn-01 hesc line ![]() Hesbgn 01 Hesc Line, supplied by BresaGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hesbgn-01 hesc line/product/BresaGen Inc Average 90 stars, based on 1 article reviews
hesbgn-01 hesc line - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
BlueRock Therapeutics
cryopreserved cell product from the h9 hesc line ![]() Cryopreserved Cell Product From The H9 Hesc Line, supplied by BlueRock Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cryopreserved cell product from the h9 hesc line/product/BlueRock Therapeutics Average 90 stars, based on 1 article reviews
cryopreserved cell product from the h9 hesc line - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Geron Bio
wa07 (h7) hesc line ![]() Wa07 (H7) Hesc Line, supplied by Geron Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/wa07 (h7) hesc line/product/Geron Bio Average 90 stars, based on 1 article reviews
wa07 (h7) hesc line - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
International Stem Cell Corporation
pg hesc lines llc9p ![]() Pg Hesc Lines Llc9p, supplied by International Stem Cell Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pg hesc lines llc9p/product/International Stem Cell Corporation Average 90 stars, based on 1 article reviews
pg hesc lines llc9p - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Roslin Cell Therapies
clinical grade hesc lines ![]() Clinical Grade Hesc Lines, supplied by Roslin Cell Therapies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/clinical grade hesc lines/product/Roslin Cell Therapies Average 90 stars, based on 1 article reviews
clinical grade hesc lines - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
MStem Cell laboratories
human embryonic stem cells (hescs) um4–6 nih registry #0147 ![]() Human Embryonic Stem Cells (Hescs) Um4–6 Nih Registry #0147, supplied by MStem Cell laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human embryonic stem cells (hescs) um4–6 nih registry #0147/product/MStem Cell laboratories Average 90 stars, based on 1 article reviews
human embryonic stem cells (hescs) um4–6 nih registry #0147 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Roslin Cell Therapies
hesc line rc-9 ![]() Hesc Line Rc 9, supplied by Roslin Cell Therapies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hesc line rc-9/product/Roslin Cell Therapies Average 90 stars, based on 1 article reviews
hesc line rc-9 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: PLoS ONE
Article Title: Pathogen Sensing Pathways in Human Embryonic Stem Cell Derived-Endothelial Cells: Role of NOD1 Receptors
doi: 10.1371/journal.pone.0091119
Figure Lengend Snippet: (A) TLR4 and NOD1 expression in hESC-EC (relative to expression in HUVEC) in vitro . Data are mean ± SEM (n = 3). Statistical significance was determined by one-sample t-test (*p<0.05) for NOD1 vs. TLR4 expression. (B) Representative immunocytochemistry images of hESC-EC (top) and HUVEC (bottom) stained for the NF-κB p65-subunit (red) in response to 1 hour treatment with or without, C12-iE-DAP (NOD1 agonist; 10 µg/ml), LPS (TLR4 agonist; 1 µg/ml) or IL-1β (1 ng/ml). Nuclei were stained with DAPI (blue; 5 µg/ml). Images were acquired using a Cellomics VTi HCS Arrayscanner with a CarlZeiss microscope. (C) LPS (TLR4 agonist; 1 µg/ml) and C12-iE-DAP (NOD1 agonist; 10 µg/ml) induced CXCL8 release after 24 hour stimulation. Data are mean ± SEM. For HUVEC, hESC-EC or BOEC, n = 4–8. For iPSC-EC, n = 2, single isolation. Statistical significance was determined by one-way ANOVA followed by Dunnett's multiple comparison test for each cell type (*p<0.05) and by two-way ANOVA followed by Bonferroni's post-test for between cell types. Analysis was not performed on data from iPSC-EC.
Article Snippet: Experiments were carried out using the
Techniques: Expressing, In Vitro, Immunocytochemistry, Staining, Microscopy, Isolation, Comparison
Journal: PLoS ONE
Article Title: Pathogen Sensing Pathways in Human Embryonic Stem Cell Derived-Endothelial Cells: Role of NOD1 Receptors
doi: 10.1371/journal.pone.0091119
Figure Lengend Snippet: MSD analysis of cytokine (pg/ml) release from hESC-EC.
Article Snippet: Experiments were carried out using the
Techniques:
Journal: PLoS ONE
Article Title: Pathogen Sensing Pathways in Human Embryonic Stem Cell Derived-Endothelial Cells: Role of NOD1 Receptors
doi: 10.1371/journal.pone.0091119
Figure Lengend Snippet: TLR4 and NOD1 expression in (A) hESC-EC and (B) HUVEC before (pre-implant; open bars) and 21 days after (post-implant; filled bars) implantation in vivo (‘conditioning’). Data are mean ± SEM and are normalized at unity (1) to gene levels in pre-implant cells. HUVEC; NOD1 pre-implant n = 8, post implant n = 4: HUVEC; TLR4 pre-implant n = 10, post implant n = 3. hESC-ECs; NOD1 pre-implant n = 6, post implant n = 5: hESC-ECs; TLR4 pre-implant n = 10, post implant n = 6. Data was obtained from 2 independent experiments (using up to 12 rats per group). Statistical significance was determined by one-sample t-test where results were compared to a theoretical control of 1 (*p<0.05). ND = none detectable.
Article Snippet: Experiments were carried out using the
Techniques: Expressing, In Vivo, Control
Journal: PLoS ONE
Article Title: Pathogen Sensing Pathways in Human Embryonic Stem Cell Derived-Endothelial Cells: Role of NOD1 Receptors
doi: 10.1371/journal.pone.0091119
Figure Lengend Snippet: (A) Effect of LPS (1 µg/ml) or C12-iE-DAP (10 µg/ml) on CXCL8 release from hESC-EC and HUVEC after 24 hours. (B) Effect of Haemophilus influenzae (HIN) (10 5 –10 8 CFU/ml) on CXCL8 release from hESC-EC (solid line) or HUVEC (dashed line) after 24 hours. Data are mean ± SEM; n = 3 representative of 6 hESC-EC isolations. Statistical significance for responses to drugs or bacteria was determined by one-way ANOVA followed by Dunnett's multiple comparison test (p<0.05).
Article Snippet: Experiments were carried out using the
Techniques: Bacteria, Comparison
Journal: PLoS ONE
Article Title: Pathogen Sensing Pathways in Human Embryonic Stem Cell Derived-Endothelial Cells: Role of NOD1 Receptors
doi: 10.1371/journal.pone.0091119
Figure Lengend Snippet: (A) Relative expression (vs. GAPDH) of NOD1 following 48 hour incubation with NOD1 siRNA normalized to non-targeting siRNA; n = 6. (B) CXCL8 release from hESC-EC following 48 hour pre-incubation with non-targeting siRNA (open bars) or NOD1-siRNA (filled bars) and 24 hour treatment +/− C12-iE-DAP (10 µg/ml) or Haemophilus influenzae (HIN) (10 7 –10 8 CFU/ml); n = 7–8. (C) Effect of GSK'214 (300 nM; RIP2 inhibitor) or GSK'217 (300 nM; NOD1 inhibitor), given 30 minutes before a 24 hour treatment with HIN (10 7 CFU/ml) or C12-iE-DAP (10 µg/ml) on CXCL8 release; n = 4. It should be noted that GSK drugs increased CXCL8 release under basal conditions; for each experiment this was subtracted from treatment groups. For panel A, statistical significance was determined by one-sample t-test. For panel B statistical significance within siRNA groups was determined by one-way ANOVA followed by Dunnett's multiple comparison test (*p<0.05), and between groups by two-way ANOVA followed by Bonferroni's post-test (+p<0.05). For panel C statistical significance for the effects of inhibitor of C12-iE-DAP or HIN induced CXCL8 was determined by one-way ANOVA followed by Dunnett's multiple comparison test (*p<0.05).
Article Snippet: Experiments were carried out using the
Techniques: Expressing, Incubation, Comparison
Journal: Stem cells (Dayton, Ohio)
Article Title: Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury
doi: 10.1002/stem.245
Figure Lengend Snippet: hESC-derived OPC expression profile. (a): More than 90% of cells labeled with the chondroitin sulfate proteoglycan NG2 (red), associated with oligodendrocyte precursors. (b): A total of 72 ± 2% of cells expressed the cell surface tyrosine kinase receptor for platelet-derived growth factor, PDGFRα (red), associated with oligodendrocyte progenitors. No cells were detected that expressed the embryonic stem cell markers Oct-4 and SSEA4 or the neural development transcription factor Pax6 (black bars) (c). Fewer than 5% of cells expressed the less mature OPC marker, A2B5, or the more mature oligodendroglial markers, O4 and RIP (red bars) (c). Some cells (<5% each) were positive for the non-oligodendroglial markers GFAP and Tuj1 (green bars) (c). (d): Detection of selected mRNA expression by RT-PCR. Scale bar: a, 60μm; b 45 μm.
Article Snippet: Derivation of OPCs from hESCs The
Techniques: Derivative Assay, Expressing, Labeling, Marker, Reverse Transcription Polymerase Chain Reaction
Journal: Stem cells (Dayton, Ohio)
Article Title: Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury
doi: 10.1002/stem.245
Figure Lengend Snippet: Transplantation of hESC-derived OPCs into acute SCI resulted in cell survival, limited migration from the site of implantation, and differentiation to mature oligodendrocytes. (a): The distribution of hESC-derived OPCs was detected using anti-human-positive nuclei staining (brown). No human cells were detected in control animals. (b): Close image of transplant area reveals non-human cells (blue-green) among the anti-human nuclei-positive, transplanted cells (brown). Within the transplant area, human nuclei positive cells were homogeneously distributed and were not located in discrete clusters or rosette-like formations in any of the transplanted animals as might suggest neuroblastoma/glioma. (c): Distribution of total numbers of anti-human nuclei-positive cells within spinal cord transverse sections along the cranial-caudal axis. Cells were significantly localized to the injury epicenter (* p < 0.001, error bars represent ±SEM). Inset panels illustrate limited distribution of transplanted OPCs (black punctuation) in dorsal column. (d): Clusters of anti-human nuclei-positive cells (green) double labeled with Olig1 (red) within a region of high concentration of human nuclei-positive cells. (e): 2–3 mm from the injury epicenter, human-specific CXCR4 (red) cells localized to sites of rat/mouse-specific CXCL12 (green), suggesting that the transplanted cells responded to host cell-migration cues. (f): Anti-human nuclei-positive cells (HuNu, green) double-labeled (arrows) with the mature oligodendrocyte marker APC/CC1 (red) detected within a region of white matter. Endogenous APC/CC1-positive oligodendrocytes were present within the white matter of transplants and controls. (g): Double-labeling of anti-human nuclei (HuNu, green) and APC/CC1 (red) was confirmed by 3-D reconstruction of confocal scanned thin-plane images (large arrow in f and g). No human cells were found that colabeled with the astrocytes marker, GFAP, the neuronal marker, NeuN, or the pluripotent marker, Oct-4 (data not shown). Scale bar: a, 1.25 mm; b, d, 45 μm; e, 200 μm; f, 90 μm; g, 8 μm.
Article Snippet: Derivation of OPCs from hESCs The
Techniques: Transplantation Assay, Derivative Assay, Migration, Staining, Control, Labeling, Concentration Assay, Marker
Journal: Stem cells (Dayton, Ohio)
Article Title: Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury
doi: 10.1002/stem.245
Figure Lengend Snippet: hESC-derived OPC-transplants to cervical SCI significantly improved forelimb motor function. (a): Recovery of forelimb mean stride length significantly improved in the transplanted group relative to the non-transplanted group. The improvement was significant from at least 4 weeks after transplantation through the duration of the testing (* p < 0.01). The mean stride length of uninjured animals that were trained to the same apparatus for 9 weeks was 17.5 cm (dashed line). (b): The range of proximal forelimb motion in degrees was significantly increased in the transplant group compared to the non-transplanted group (* p < 0.01). (c): The increased range of proximal forelimb motion was resolved to the lift-off (rear-most) position of the step as opposed to the placement (fore-most) by measurement of the inside angle between the forelimb and the floor at lift-off and placement (* p < 0.01). (d): The occurrence of steps that pass the perpendicular plane is significantly increased from frequent (>50%) in the transplant group versus occasional (≤50%) in the control group (** p < 0.001). Error bars represent ±SEM.
Article Snippet: Derivation of OPCs from hESCs The
Techniques: Derivative Assay, Transplantation Assay, Control
Journal: Stem cells (Dayton, Ohio)
Article Title: Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury
doi: 10.1002/stem.245
Figure Lengend Snippet: Histopathogenesis in transplanted and non-transplanted animals. (a): Microthin sections from non-transplanted animals demonstrate myelin pathology concentrated around the dorsal and medial-ventral white matter and cavitation that eliminates a large portion of gray matter. (b): Transplanted animals lack cavitation and myelin pathology is less extensive compared to non-transplanted animals. (c): The dorsal column along the cavitation (cav) contains mostly Schwann cell (SC)-remyelinated axons (sc) with an edge that is consistent with scar formation. (d): In contrast to non-transplanted animals (c), the dorsal column of transplanted animals contains mostly normally myelinated axons (n) and no delineation between the transplanted (trans) and host cells. (e): Myelin pathology in non-transplanted animals shows thin oligodendrocyte remyelination (o), partitioned SC-remyelination (sc), and few small diameter axons. Inset illustrates the thin myelin sheath characteristic of oligodendrocyte remyelination. (f): Transplanted animal spinal cords contained hypercellularity and extra-axonal swelling, spared myelination (n), as well as more small diameter axons compared to controls. (g): Quantification of myelin pathology revealed a significant (*** p < 0.001) decrease in normally myelinated axons and an increase in SC-remyelinated (*** p < 0.001) and demyelinated (* p < 0.05) axons in the non-transplanted group relative to the transplanted group. These data indicate that normally myelinated and oligodendrocyte-remyelinated axons constitute about 95% of the total axon population within the area of dorsal column pathology in transplanted animals. (h): hESC-derived OPC transplants had significantly (*** p < 0.001) more oligodendrocyte-remyelinated axons relative to SC-remyelinated and demyelinated axons than controls. The transplants increased oligodendrocyte-remyelination efficiency to approximately 6.8-fold. Error bars represent ±SEM. Scale bar: a, b, 1.25 mm; c, d, 60 μm; e, 30 μm; f, 40 μm.
Article Snippet: Derivation of OPCs from hESCs The
Techniques: Derivative Assay